Asset Details
Do you wish to reserve the book?
Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer
Do you wish to request the book?
Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Editorial: Novel reliable approaches for prediction and clinical decision-making in cancer
2025
Overview
Although significant progress has been made in recent decades in understanding thedevelopment and progression of cancer, cancer remains one of the leading causes of death.Recent insights on immunobiological dysregulations involved in the development andprogression of cancer demonstrate the complexity and heterogeneity of cancer, which playcrucial role in the pharmacokinetic variability of cancer therapies. With regard to theprevalence of recurrence/metastases and prognosis, as well as the prediction of cancertreatment success, further investigations are urgently needed to establish cancer signaturesor treatment modalities that enable improved risk stratification and improved patientmanagement. This Research Topic focuses on studies that integrate new comprehensivesystemic, combinatorial, or complexed data that could be useful to develop personalizedtreatment regimens, to improve immunotherapies and clinical decision-making.
